These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 23255514)

  • 41. Pipelle for Pregnancy (PIP): study protocols for three randomised controlled trials.
    Lensen S; Martins W; Nastri C; Sadler L; Farquhar C
    Trials; 2016 Apr; 17(1):216. PubMed ID: 27121007
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risk of cancer in the offspring of women who underwent ovarian stimulation for IVF.
    Klip H; Burger CW; de Kraker J; van Leeuwen FE;
    Hum Reprod; 2001 Nov; 16(11):2451-8. PubMed ID: 11679537
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Middle cerebral artery thrombosis after IVF and ovarian hyperstimulation: a case report.
    Jing Z; Yanping L
    Fertil Steril; 2011 Jun; 95(7):2435.e13-5. PubMed ID: 21601668
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clomiphene citrate and letrozole to reduce follicle-stimulating hormone consumption during ovarian stimulation: systematic review and meta-analysis.
    Bechtejew TN; Nadai MN; Nastri CO; Martins WP
    Ultrasound Obstet Gynecol; 2017 Sep; 50(3):315-323. PubMed ID: 28236310
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Minimal stimulation IVF vs conventional IVF: a randomized controlled trial.
    Zhang JJ; Merhi Z; Yang M; Bodri D; Chavez-Badiola A; Repping S; van Wely M
    Am J Obstet Gynecol; 2016 Jan; 214(1):96.e1-8. PubMed ID: 26259908
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effect of G-CSF on infertile women undergoing IVF treatment: A meta-analysis.
    Li J; Mo S; Chen Y
    Syst Biol Reprod Med; 2017 Aug; 63(4):239-247. PubMed ID: 28632452
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The possible association between in vitro fertilization treatments and cancer development.
    Lerner-Geva L; Geva E; Lessing JB; Chetrit A; Modan B; Amit A
    Int J Gynecol Cancer; 2003; 13(1):23-7. PubMed ID: 12631215
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Is the type of gonadotropin-releasing hormone suppression protocol for ovarian hyperstimulation associated with ectopic pregnancy in fresh autologous cycles for in vitro fertilization?
    Londra L; Moreau C; Strobino D; Bhasin A; Zhao Y
    Fertil Steril; 2016 Sep; 106(3):666-72. PubMed ID: 27320035
    [TBL] [Abstract][Full Text] [Related]  

  • 49. GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies in IVF patients.
    Humaidan P; Polyzos NP; Alsbjerg B; Erb K; Mikkelsen AL; Elbaek HO; Papanikolaou EG; Andersen CY
    Hum Reprod; 2013 Sep; 28(9):2511-21. PubMed ID: 23753114
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Are infertility treatments a potential risk factor for cancer development? Perspective of 30 years of follow-up.
    Lerner-Geva L; Rabinovici J; Olmer L; Blumstein T; Mashiach S; Lunenfeld B
    Gynecol Endocrinol; 2012 Oct; 28(10):809-14. PubMed ID: 22475084
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cancer morbidity in a cohort of 9175 Finnish women treated for infertility.
    Yli-Kuha AN; Gissler M; Klemetti R; Luoto R; Hemminki E
    Hum Reprod; 2012 Apr; 27(4):1149-55. PubMed ID: 22343550
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A mild ovarian stimulation strategy in women with poor ovarian reserve undergoing IVF: a multicenter randomized non-inferiority trial.
    Youssef MA; van Wely M; Al-Inany H; Madani T; Jahangiri N; Khodabakhshi S; Alhalabi M; Akhondi M; Ansaripour S; Tokhmechy R; Zarandi L; Rizk A; El-Mohamedy M; Shaeer E; Khattab M; Mochtar MH; van der Veen F
    Hum Reprod; 2017 Jan; 32(1):112-118. PubMed ID: 27836979
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dynamic antimüllerian hormone levels during controlled ovarian hyperstimulation predict in vitro fertilization response and pregnancy outcomes.
    Styer AK; Gaskins AJ; Brady PC; Sluss PM; Chavarro JE; Hauser RB; Toth TL
    Fertil Steril; 2015 Nov; 104(5):1153-61.e1-7. PubMed ID: 26315051
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The possible association between IVF and breast cancer incidence.
    Pappo I; Lerner-Geva L; Halevy A; Olmer L; Friedler S; Raziel A; Schachter M; Ron-El R
    Ann Surg Oncol; 2008 Apr; 15(4):1048-55. PubMed ID: 18214616
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Does salpingectomy have a deleterious impact on ovarian response in in vitro fertilization cycles?
    Yoon SH; Lee JY; Kim SN; Chung HW; Park SY; Lee C
    Fertil Steril; 2016 Oct; 106(5):1083-1092.e5. PubMed ID: 27336211
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Risk reduction of endometrial and ovarian cancer after bisphosphonates use: A meta-analysis.
    Zhang XS; Zhang YM; Li B; Fan B; Zhao Y; Yang SJ
    Gynecol Oncol; 2018 Sep; 150(3):509-514. PubMed ID: 29960711
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Endometrial injury to overcome recurrent embryo implantation failure: a systematic review and meta-analysis.
    Potdar N; Gelbaya T; Nardo LG
    Reprod Biomed Online; 2012 Dec; 25(6):561-71. PubMed ID: 23063812
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies.
    Meirow D; Raanani H; Maman E; Paluch-Shimon S; Shapira M; Cohen Y; Kuchuk I; Hourvitz A; Levron J; Mozer-Mendel M; Brengauz M; Biderman H; Manela D; Catane R; Dor J; Orvieto R; Kaufman B
    Fertil Steril; 2014 Aug; 102(2):488-495.e3. PubMed ID: 24934489
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in vitro fertilization or intracytoplasmic sperm injection.
    Qin N; Chen Q; Hong Q; Cai R; Gao H; Wang Y; Sun L; Zhang S; Guo H; Fu Y; Ai A; Tian H; Lyu Q; Daya S; Kuang Y
    Fertil Steril; 2016 Aug; 106(2):334-341.e1. PubMed ID: 27114329
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In-vitro maturation versus IVF with GnRH antagonist for women with polycystic ovary syndrome: treatment outcome and rates of ovarian hyperstimulation syndrome.
    Das M; Son WY; Buckett W; Tulandi T; Holzer H
    Reprod Biomed Online; 2014 Nov; 29(5):545-51. PubMed ID: 25262236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.